Related Experiment Video
Updated: Jun 26, 2026
06:17
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Small-molecule peptides inhibit Z alpha1-antitrypsin polymerization.
Yi-Pin Chang1, Ravi Mahadeva2, Wun-Shaing W Chang3
1Department of Chemistry and Biochemistry, National Chung Cheng University,Chia-Yi, Taiwan, Republic of China.
Journal of Cellular and Molecular Medicine
|January 6, 2009
Summary
A novel peptide inhibitor, Ac-TTAI-NH(2), effectively blocks pathogenic polymerization of Z alpha1-antitrypsin (AAT), offering a potential therapeutic strategy for AAT-related liver and lung diseases.
Area of Science:
- Biochemistry and Molecular Biology
- Drug Discovery and Development
Background:
- The Z variant of alpha1-antitrypsin (AAT) causes liver cirrhosis and emphysema due to its polymerization and deficiency.
- Current treatments for Z AAT disease are limited, necessitating novel therapeutic approaches.
Purpose of the Study:
- To develop a peptide-based inhibitor to arrest the pathogenic polymerization of Z AAT.
- To identify and characterize a high-affinity peptide ligand for Z AAT.
Main Methods:
- A combinatorial approach was employed to identify peptide inhibitors targeting Z AAT.
- Gel electrophoresis and biosensor analysis were used to characterize peptide binding affinity and specificity.
- In silico modeling was utilized to predict peptide-protein interactions.
Main Results:
- The peptide Ac-TTAI-NH(2) demonstrated significantly improved binding specificity and affinity for Z AAT compared to previous inhibitors.
- This peptide effectively inhibited Z AAT polymerization and promoted the dissociation of existing oligomers.
- Ac-TTAI-NH(2) showed no cytotoxicity to lung cell lines.
Conclusions:
- Ac-TTAI-NH(2) is a potent and specific inhibitor of Z AAT polymerization.
- This peptide represents a promising therapeutic candidate for treating Z AAT-related liver and lung diseases.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.